Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F67M7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,599
Award facts
- Contract value 100% obligated
- $13,598.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,598.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication on February 4, 2026, with completion expected by February 5, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol in patients at risk for cardiovascular disease, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing commitment to providing specialty pharmaceuticals to military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2031), which serves as a comprehensive global pharmaceutical support vehicle for military treatment facilities and veteran healthcare programs. AmerisourceBergen's demonstrated capability to compete successfully for federal pharmaceutical procurement, combined with its established role as a prime vendor for the Defense Health Agency and other government healthcare systems, positions it to efficiently fulfill specialized medication requirements across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F67M7?
SPE2DR26F67M7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F67M7 worth?
The government has obligated $13,599 on SPE2DR26F67M7.
Is contract SPE2DR26F67M7 an order under another contract?
Yes. SPE2DR26F67M7 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67M7 competed?
The extent of competition for SPE2DR26F67M7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award